Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02108912 · ClinicalTrials.gov registry record · NA

Metabolic Costs of Walking Post Stroke

A NA study of Acute Stroke, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT02108912 is a NA study of Acute Stroke that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 16 participants, below the 6,124-participant average among 10 other Acute Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02108912, a NA study of Acute Stroke, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This will be a randomized, matched-group study to compare the cardiopulmonary / metabolic benefits for persons post stroke that learn to walk utilizing early treadmill training post-acute stroke to persons post stroke that learn to walk utilizing non-treadmill based gait training during the same time period. Participants (n=30) will be adults who have completed acute rehabilitation following a stroke. Random assignment will be to either the ESTT or traditional gait training protocol during the outpatient rehabilitation phase. 1. Group A: Traditional outpatient therapy (n = 15) 2. Group B: Treadmill training (ESTT) outpatient therapy (n = 15)

Conditions Studied

Interventions

  • OTHER ESTT
  • OTHER Traditional outpatient

Study Locations (1)

Texas

  • UT Southwestern School of Health Professions - Dallas

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2014-03
Est. Completion 2017-01
Phase NA

What the Registry Record Tells You About NCT02108912

The ClinicalTrials.gov registry entry for NCT02108912 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,124-participant average among 10 other Acute Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Stroke appearing as the primary indexed condition, and to 2 interventions - of which ESTT is the first listed.

NCT02108912 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02108912 about?

NCT02108912 is a clinical study titled "Metabolic Costs of Walking Post Stroke". This will be a randomized, matched-group study to compare the cardiopulmonary / metabolic benefits for persons post stroke that learn to walk utilizing early treadmill training post-acute stroke to persons post stroke that learn to walk utilizing non-treadmill based gait training during the same tim...

What is the current status of trial NCT02108912?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2014-03. Estimated completion is 2017-01.

What conditions does trial NCT02108912 study?

This clinical trial studies the following conditions: Acute Stroke.

What interventions are being tested in trial NCT02108912?

The interventions under investigation include: ESTT (OTHER), Traditional outpatient (OTHER).

Who is sponsoring clinical trial NCT02108912?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02108912 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.